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INFORMATION FOR AUTHORS
The Editors of Hematology/Oncology and Stem Cell Therapy wel-
come contributions from our readers. We seek high quality clinical 
and basic research reports in hematology and oncology, including 
the use of stem cell therapy in treating hematologic diseases and 
malignancies, from throughout the world, but particularly from 
countries whose research might be underrepresented in the current 
medical literature. Priority will be given to manuscripts that have 
a greater public health impact or that highlight unique geographic 
distributions or behaviors of blood diseases or cancer. We publish 
original research reports, brief communications, reviews, editorials, 
special communications, letters and case reports. 
SUBMISSION OF MANUSCRIPTS
Manuscripts are received with the understanding that they are not 
under simultaneous consideration by another publication. If an ab-
stract of the work has previously been published or if manuscripts 
using the same database or relating to the same topic have been 
published or submitted by any of the authors, this should be dis-
closed. Authors who violate this requirement will be subject to an 
extended publication ban. An abstract published prior to a full report 
is not regarded as a duplicate publication. Accepted manuscripts 
may not be published elsewhere without the journal’s permission. 
Manuscripts should be submitted online at http://hemoncstem.ed-
mgr.com. To ensure that peer review is double-blinded, there should 
be no title page in the file of the manuscript that is submitted on-
line. The file name should not include the author’s name or other 
identifying text. Portions of the submission (photographs, artwork, 
etc.) may be sent by mail if necessary, but we prefer that these be 
prepared in digital form and submitted online. If you have difficulty, 
contact us by e-mail at admin@hemoncstem.net. 
MANUSCRIPT PREPARATION
The format of Hematology/Oncology and Stem Cell Therapy com-
plies with the “Uniform Requirements for Manuscripts Submitted 
to Biomedical Journals” published by the International Committee 
of Medical Journal Editors (see http://www.icmje.org for the latest 
updated version). We encourage the use of reporting guidelines 
such the CONSORT statement for randomized, controlled trials and 
the STROBE statement for observational studies (see http://www.
equator-network.org/). For human gene nomenclature, see the in-
structions at the back of the journal. Manuscripts, including tables, 
references, and figure legends, must be prepared using a word pro-
cessing program, preferably Microsoft Word, and submitted online. 
Before submitting a manuscript, create an account on the website 
(http://hemoncstem.edmgr.com). When you submit the manuscript 
online, a current email address must be provided for all authors. Ab-
stract. All manuscripts must contain an abstract of not more than 300 
words. The abstract should be structured with the following head-
ing: Background and Objectives, Design and Setting, Patients (or 
Subjects) and Methods, Results, and Conclusion. Manuscript Format. 
Most original research reports have the following format: Introduc-
tion (the question the paper intends to answer, what remains un-
known, how patients could benefit from the answer); Methods (study 
design and methods, operational definitions of major variables, de-
scription of the patient or subject population, and laboratory and 
statistical methods); Results (pertinent findings in a logical sequence 
with tables and figures as necessary); and Discussion (conclusions 
based on the findings, evidence from the literature that supports 
the conclusions, conflicting evidence, applicability of the conclusions, 
limitations of the study, and implications for future research or clini-
cal applications). Statistics should be described in enough detail to 
enable a knowledgeable reader, with access to the original data, to 
verify the reported results. Authors might consult recent issues of 
the journal for examples of appropriate style and format. Word count 
limits are 3500 words for original research reports, 2000 for brief 
communications, case reports, and mini-reviews, and 750 for letters. 
The word count should include references listed at the end of the ar-
ticle. References. List references in consecutive numerical order (the 
order of citation in the manuscript, and not alphabetically). Once a 
reference is cited, all subsequent citations should be to the origi-
nal number. All references must be cited in the text or tables. 
References to journal articles should be formatted in NLM style 
(www.nlm.nih.gov/citingmedicine/). References to material on 
the Internet should include the date of access. Manuscripts with 
incorrectly formatted citations will be returned to the author 
for correction. The author is responsible for the accuracy and 
completeness of the references and for their correct textual ci-
tation. In-text reference numbers should be superscripted and 
placed after the period (not in parentheses), as at the end of 
this sentence.1 Unit of measurement. With the exception of 
blood pressure, all units of measurement and laboratory values 
must be expressed in SI units; conventional units may be in-
cluded parenthetically. For normally distributed data, report the 
mean and standard deviation as (for example): 38.9 (9.4), not 
as 38.9±9.4. The international nonproprietary name should be 
used for drugs with mention of the trade name on first mention. 
Authors should consult recent issues of the journal for examples 
of appropriate style and format. Illustrations. Photographs, 
scientific graphs and other illustrations should be uploaded as 
separate files, not embedded in Microsoft Word. The format 
should be .TIF or .EPS at 300 dpi (dots per inch) or greater 
resolution. Files in the .JPEG format (high resolution) may be 
acceptable if there is difficulty uploading larger files. These file 
saving options can be found in most software in the ‘Save As’ 
or ‘Export’ commands under the ‘File’ menu. Save original files 
in the event that submitted files are not suitable for publication. 
Graphs must be digitally scanned, if not prepared initially as 
an electronic file in a scientific graphing program. Simple line 
and bar charts are usually sufficient. Written permission must 
accompany any photograph in which the subject can be identi-
fied or any illustration that has been previously published. All 
illustrations (“figures”) must be numbered as cited in the text 
in consecutive numeric order. For photomicrographs, the legend 
should include the original magnification and stain used. Tables. 
Tables should be prepared using the Table function in Microsoft 
Word. It is not necessary to submit tables in a separate file from 
the main document. Verify tabular statistics to make sure they 
tally and match data cited in the text and abstract.
SCIENTIFIC MISCONDUCT
We follow the guidelines of the Committee on Publication Ethics 
(http://publicationethics.org) on duplicate publication, fabricat-
ed data, undisclosed conflict of interest, plagiarism and other 
issues of publication and scientific misconduct. Authors will be 
banned from submitting to the Hematology/Oncology and Stem 
Cell Therapy in the future and their institutions notified when 
misconduct is encountered.
RESPONSIBILITIES OF AUTHORS
The authors are entirely responsible for accuracy of all state-
ments and data (including drug dosages) contained in the man-
uscript, accuracy of all reference information, and for obtaining 
and submitting permission from the author and publisher of any 
previously published material included in the submitted manu-
script. The author should identify any financial support for the 
research in an acknowledgment in the manuscript. The cor-
responding author of accepted manuscripts will receive an ed-
ited manuscript for “final author approval.” The author should 
review this carefully, as he is responsible for all changes in his 
work, including those made in final editing.
INFORMED CONSENT
All manuscripts reporting the results of experimental investiga-
tion involving human subjects should include a statement con-
firming that informed consent was obtained from each subject 
or subject’s guardian, after approval of the experimental proto-
col by a local human ethics committee. (September 2011)
